Physician profile
John J Callaghan
NPI 1154316636
$23,277,500.18
in general payments reported to CMS, 2019-2025
4 companies · $3.0M in 2025
The $3.0M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5.0M · 2020: $4.1M · 2021: $3.9M · 2022: $2.4M · 2023: $2.7M · 2024: $2.2M · 2025: $3.0M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $7.8M · Consulting Fee: $29K · Travel and Lodging: $1,556 · Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $7,820,025.14 |
| Consulting Fee | $29,158.57 |
| Travel and Lodging | $1,555.98 |
| Food and Beverage | $724.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $23,166,122.84 | 2019-2025 | Attune, Sigma, Summit |
| Medical Device Business Services, INC. | $111,280.64 | 2019-2025 | Attune |
| Globus Medical, INC. | $72.10 | 2022 | |
| Covidien Lp | $24.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Callaghan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.